What routine health checks can reveal about your overall condition

# What routine health checks can reveal about your overall condition

Routine health checks form the cornerstone of preventative medicine, offering you a comprehensive snapshot of your physiological status before symptoms develop. These assessments combine laboratory investigations, clinical examinations and diagnostic imaging to detect early markers of disease, allowing timely intervention when treatment outcomes are most favourable. Whether you’re attending an NHS Health Check, a private wellness assessment, or age-specific screening programmes, understanding what these tests reveal about your health empowers you to make informed decisions about your lifestyle and medical care.

The value of regular health monitoring extends beyond disease detection. Many chronic conditions—including cardiovascular disease, diabetes, kidney dysfunction and certain cancers—develop silently over years, progressing without noticeable symptoms until significant organ damage has occurred. By the time you experience symptoms such as chest pain, excessive thirst, or unexplained weight loss, the underlying pathology may already be advanced. Routine assessments catch these conditions during their earliest, most treatable phases, dramatically improving your long-term prognosis and quality of life.

Modern health checks have evolved considerably from simple physical examinations. Today’s comprehensive assessments incorporate sophisticated biomarker analysis, genetic risk profiling, and advanced imaging techniques that can identify subclinical abnormalities years before they would otherwise become apparent. This proactive approach shifts healthcare from reactive treatment to preventative management, reducing both the burden of chronic disease and the associated healthcare costs that accumulate when conditions are diagnosed late.

Comprehensive blood panel analysis: haematological and biochemical markers

Blood testing represents the most information-rich component of any health assessment, providing quantitative data on hundreds of physiological parameters simultaneously. A single venous sample yields insights into your haematological status, metabolic function, organ health, nutritional deficiencies, inflammatory processes and endocrine balance. The sophistication of modern laboratory medicine means that even subtle deviations from reference ranges can flag early pathological changes, often before you notice any symptoms whatsoever.

Full blood count (FBC) parameters: detecting anaemia, infection and haematological disorders

The Full Blood Count examines the cellular components of your blood, measuring red blood cells, white blood cells and platelets along with their various subtypes. Haemoglobin concentration and red cell indices reveal different forms of anaemia—whether caused by iron deficiency, vitamin B12 or folate depletion, chronic disease, or inherited conditions such as thalassaemia. Low haemoglobin explains symptoms of fatigue, breathlessness and poor exercise tolerance that you might otherwise attribute to stress or ageing.

White blood cell analysis provides crucial information about your immune status and infection risk. Elevated neutrophils typically indicate bacterial infection or inflammatory processes, whilst increased lymphocytes may suggest viral infection or, occasionally, haematological malignancies. Eosinophil counts rise with allergic conditions and parasitic infections. Platelet numbers and morphology assess your clotting function—low counts increase bleeding risk, whilst elevated platelets may accompany inflammatory conditions or, rarely, myeloproliferative disorders. These patterns guide further investigation when abnormalities are detected.

Lipid profile assessment: total cholesterol, HDL, LDL and triglyceride ratios

Your lipid profile quantifies the various cholesterol fractions and triglycerides circulating in your bloodstream, providing essential data for cardiovascular risk stratification. Total cholesterol alone offers limited clinical value; the balance between high-density lipoprotein (HDL, the “protective” cholesterol) and low-density lipoprotein (LDL, the “harmful” fraction) determines your actual atherosclerotic risk. An optimal lipid profile shows total cholesterol below 5.0 mmol/L, LDL below 3.0 mmol/L, HDL above 1.0 mmol/L for men or 1.2 mmol/L for women, and triglycerides under 1.7 mmol/L.

Deviations from these targets significantly increase your risk of coronary artery disease, stroke and peripheral vascular disease over time. Elevated LDL cholesterol deposits within arterial walls, forming atherosclerotic plaques that narrow vessels and predispose to thrombosis. High triglycerides often accompany

triglycerides and reflect how your body handles dietary fats and refined carbohydrates. Persistently raised triglycerides often cluster with low HDL, central obesity and impaired glucose tolerance, forming the metabolic syndrome that markedly elevates long-term cardiovascular risk. By contrast, high HDL cholesterol acts like a biological “clean-up crew”, helping remove excess cholesterol from artery walls. When your routine health check uncovers an adverse lipid pattern, you and your clinician can address it through targeted lifestyle measures—such as dietary modification, weight reduction and increased physical activity—and, where appropriate, lipid-lowering medication including statins.

Importantly, lipid profiles are most informative when interpreted alongside other cardiovascular markers such as blood pressure, smoking status, age and family history. A mildly elevated LDL in a young, non-smoking individual with excellent blood pressure may carry a very different absolute risk from the same LDL level in a middle-aged smoker with hypertension. This is why modern health assessments integrate your cholesterol levels into formal cardiovascular risk calculators rather than viewing them in isolation. Regular repeats of your lipid profile also allow you to track the impact of any lifestyle changes or pharmacological treatments over time.

Glycaemic control indicators: HbA1c and fasting glucose testing for diabetes screening

Glycaemic markers assess how effectively your body regulates blood sugar, providing crucial information about your risk of developing type 2 diabetes and its complications. Fasting plasma glucose gives a snapshot of your blood sugar level after an overnight fast, whereas HbA1c reflects your average glucose control over the preceding 8–12 weeks by measuring the proportion of haemoglobin molecules that have become “glycated” by circulating sugar. An HbA1c between 42 and 47 mmol/mol (6.0–6.4%) usually signals prediabetes, while values at or above 48 mmol/mol (6.5%) are diagnostic of diabetes in most clinical contexts.

Why does this matter if you feel completely well? Chronic, mildly elevated blood glucose silently injures blood vessels and nerves, increasing your risk of heart disease, stroke, kidney failure, blindness and peripheral neuropathy years before classic symptoms such as thirst, frequent urination or unexplained weight loss appear. Routine screening as part of a health check is particularly important if you are overweight, have a family history of diabetes, belong to a high-risk ethnic group, or have conditions such as polycystic ovary syndrome or hypertension. Identifying impaired glucose regulation early gives you a powerful window of opportunity to reverse or delay progression through dietary changes, increased physical activity and, where appropriate, medications such as metformin.

Interpreting HbA1c and fasting glucose together offers a more nuanced view of your glycaemic health. For instance, a normal fasting glucose with a borderline raised HbA1c may indicate that your post-meal sugars are higher than ideal, a pattern often seen in early insulin resistance. Conversely, discrepancies between these markers can occasionally flag underlying issues such as anaemia or haemoglobin variants, which may affect HbA1c accuracy and prompt your clinician to use alternative measures like fructosamine. In all cases, your routine health check results should translate into a clear, personalised plan to optimise your blood sugar control.

Hepatic and renal function tests: ALT, AST, creatinine and eGFR measurements

Liver and kidney function tests provide vital information about two of your body’s main detoxification and filtration systems. Serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) reflect hepatocellular integrity—elevations may signal fatty liver disease, viral hepatitis, alcohol-related damage, medication effects or, more rarely, autoimmune or genetic liver disorders. Gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP), often measured at the same time, help distinguish between liver cell injury and bile duct obstruction patterns. Mild, isolated abnormalities are common and usually benign, but persistent or marked derangements warrant further investigation.

Renal function is typically assessed by measuring serum creatinine, urea and calculating the estimated glomerular filtration rate (eGFR). Creatinine, a breakdown product of muscle metabolism, accumulates in the blood when kidney filtration declines. eGFR adjusts creatinine for age, sex and sometimes ethnicity to estimate how well your kidneys are working; values below 60 mL/min/1.73 m² sustained over three months suggest chronic kidney disease. Because early kidney dysfunction is often asymptomatic, these routine measurements can reveal problems long before you notice fluid retention, fatigue or changes in urination.

Abnormal liver and kidney tests rarely exist in a vacuum. They often interact with other risk factors uncovered in your health check, such as obesity, diabetes, high blood pressure and medication use. For example, the combination of raised ALT, elevated triglycerides and central obesity strongly suggests non-alcoholic fatty liver disease, now one of the most common liver conditions in industrialised countries. Similarly, a modest drop in eGFR accompanied by protein in the urine and long-standing hypertension points toward hypertensive nephropathy. By viewing these biochemical markers alongside your clinical profile, your clinician can recommend evidence-based strategies—ranging from weight loss and alcohol reduction to blood pressure optimisation and medication review—to protect your liver and kidney function over the long term.

Thyroid stimulating hormone (TSH) evaluation for metabolic dysfunction

The thyroid gland exerts a profound influence on your metabolism, energy levels, heart rate and mood. Measuring thyroid stimulating hormone (TSH) during a routine health check is one of the most sensitive ways to detect thyroid dysfunction. When your thyroid underperforms (hypothyroidism), TSH rises as the pituitary gland tries to stimulate greater hormone production; when it is overactive (hyperthyroidism), TSH falls because the pituitary senses excessive circulating thyroid hormones. Even subtle deviations outside the laboratory reference range can explain non-specific symptoms such as tiredness, weight change, feeling cold, palpitations or mood disturbances that might otherwise be dismissed.

In many cases, an abnormal TSH result will be followed by measurement of free thyroxine (FT4) and, sometimes, free triiodothyronine (FT3) to clarify the pattern of thyroid dysfunction. Subclinical hypothyroidism—where TSH is raised but FT4 remains normal—is relatively common, particularly in older adults and those with autoimmune conditions, and may or may not require treatment depending on symptom burden and cardiovascular risk. Conversely, undiagnosed hyperthyroidism can accelerate bone loss, provoke atrial fibrillation and strain the heart, making early detection through routine testing especially valuable.

From a preventative health perspective, routine TSH evaluation during a comprehensive blood panel helps ensure that treatable endocrine causes of fatigue, weight gain, heavy periods or anxiety are not overlooked. If thyroid autoimmunity is suspected—for instance, in someone with a strong family history or other autoimmune disorders—antibody testing can refine the diagnosis and prognosis. With appropriate management, most thyroid conditions can be well controlled, restoring metabolic balance and reducing long-term complications.

Cardiovascular assessment through blood pressure and electrocardiogram studies

While blood tests reveal much about your cardiovascular risk profile, direct assessment of heart function and vascular health provides equally important insights. Routine health checks typically include blood pressure measurement and, where indicated, an electrocardiogram (ECG) to evaluate your heart’s electrical activity. More advanced assessments may incorporate pulse wave analysis to gauge arterial stiffness and formal risk scoring tools to estimate your likelihood of experiencing a heart attack or stroke within the next decade. Together, these measures paint a detailed picture of your current cardiovascular status and future risk.

Hypertension staging: systolic and diastolic measurements using sphygmomanometry

Blood pressure is a fundamental vital sign, yet hypertension remains one of the most underdiagnosed and undertreated risk factors for cardiovascular disease. During a routine health check, your blood pressure is measured using a sphygmomanometer—either manual or automated—usually at your upper arm with an appropriately sized cuff. The reading captures two numbers: systolic pressure (the force as your heart contracts) and diastolic pressure (the force when your heart relaxes between beats). Persistent readings at or above 140/90 mmHg in a clinical setting, or 135/85 mmHg at home, generally indicate hypertension in adults.

Because a single elevated reading can be influenced by anxiety, caffeine, recent activity or even conversation, proper technique and repeated measurements are essential. Many clinics now follow a structured approach, taking multiple readings and sometimes arranging ambulatory or home blood pressure monitoring to confirm the diagnosis. Once established, hypertension is staged according to severity and associated organ damage, guiding treatment intensity. You might not “feel” high blood pressure, yet over years it quietly damages arteries, thickens the heart muscle and impairs kidney function, much like water slowly eroding a stone.

The good news is that blood pressure responds well to lifestyle interventions. Weight reduction, salt restriction, regular aerobic exercise, moderating alcohol and stopping smoking can all produce clinically meaningful reductions. For many people, medications such as ACE inhibitors, calcium channel blockers or diuretics are also recommended to reach target levels, particularly if there are co-existing conditions like diabetes or chronic kidney disease. Your routine health check is therefore a crucial opportunity to detect raised blood pressure early and agree a practical plan to bring it under control.

12-lead ECG interpretation: identifying atrial fibrillation and ischaemic changes

A standard 12-lead electrocardiogram records the electrical activity of your heart from multiple angles, providing a non-invasive, rapid snapshot of rhythm and conduction. In the context of a routine health assessment, an ECG is often performed if you have symptoms such as palpitations, chest discomfort, unexplained breathlessness or a history of cardiovascular disease. It may also be offered proactively in older adults, those with high blood pressure or diabetes, or before starting certain medications that affect cardiac conduction.

One of the most important arrhythmias detected by ECG is atrial fibrillation (AF), an irregular, often rapid heart rhythm that substantially increases stroke risk. AF can be intermittent and completely asymptomatic, meaning you may be unaware of its presence. Detecting it on a routine ECG allows your clinician to consider anticoagulant therapy to reduce clot-related stroke risk and manage any associated symptoms. The ECG also reveals signs of previous silent heart attacks, ongoing ischaemia (reduced blood supply to the heart muscle), conduction blocks and ventricular hypertrophy, all of which carry prognostic significance.

Interpreting an ECG requires clinical expertise, but the practical implications are straightforward for you as a patient. A normal tracing provides reassurance that your heart rhythm and conduction are currently stable, whereas abnormalities prompt further evaluation—such as echocardiography, Holter monitoring or cardiology referral. As part of a comprehensive health check, ECG findings complement your blood pressure, lipid profile and symptom history, ensuring that subtle cardiac issues are not missed until they become emergencies.

Pulse wave analysis and arterial stiffness assessment

Beyond simple blood pressure readings, more advanced cardiovascular health checks increasingly use pulse wave analysis to assess arterial stiffness. This technique measures how quickly the pressure wave generated by each heartbeat travels along your arteries—much like observing how fast ripples move across a pond to infer water depth and resistance. Stiffer arteries transmit the wave more rapidly, which is reflected in parameters such as pulse wave velocity and augmentation index. Increased arterial stiffness is an independent predictor of cardiovascular events, particularly in older adults and those with hypertension or diabetes.

Why should you care about arterial stiffness if your blood pressure and cholesterol seem acceptable? Because it offers a glimpse into the “biological age” of your vascular system, which may differ from your chronological age. For example, a middle-aged person with long-standing smoking, high blood pressure and poor glycaemic control may have markedly stiff arteries, signalling an elevated risk of heart attack or stroke despite relatively modest conventional risk factors. Conversely, favourable lifestyle habits can help preserve arterial elasticity, delaying vascular ageing.

Pulse wave analysis is typically quick and non-invasive, performed using sensors on the wrist or upper arm. While not yet part of every routine NHS Health Check, it is commonly included in comprehensive private wellness assessments. The results can be a powerful motivator for lifestyle change: seeing evidence that your arteries are “younger” or “older” than expected often brings home the impact of daily choices on cardiovascular health in a tangible way.

Cardiovascular risk calculation: QRISK3 and framingham score applications

Individual test results—blood pressure, cholesterol, smoking status, age, sex and family history—only tell part of the story. To translate these data into a meaningful estimate of your future heart attack or stroke risk, clinicians use validated risk calculators such as QRISK3 in the UK or the Framingham risk score in other settings. These tools integrate multiple variables, including some you cannot change (like age and ethnicity) and others you can (such as smoking or blood pressure), to estimate your probability of developing cardiovascular disease over the next 10 years.

During a routine health check, your clinician may share your calculated risk as a percentage—for example, “you have a 12% chance of a cardiovascular event in the next decade.” This can sound abstract, but it powerfully shapes prevention strategies. In UK practice, a 10-year QRISK3 score of 10% or more often prompts a discussion about starting statin therapy alongside lifestyle modification. Even if your score is currently low, understanding which factors drive it helps you prioritise changes that will have the greatest impact, such as stopping smoking or losing weight around your waist.

It is important to remember that risk calculators provide estimates, not guarantees. Two people with the same calculated risk may have different outcomes, but on a population level these tools are highly informative. Used wisely, they move healthcare from a one-size-fits-all model to a personalised prevention plan, ensuring that those at greatest risk receive the most intensive support and treatment.

Urinalysis and kidney function monitoring

Urinalysis is a simple yet remarkably revealing component of routine health checks, offering direct insight into how your kidneys are functioning and whether there are early signs of metabolic or urinary tract disease. A standard dipstick test assesses parameters such as protein, blood, glucose, pH, leucocytes and nitrites within minutes. When abnormalities are detected, more specific laboratory tests—such as the albumin-to-creatinine ratio—help quantify the extent of kidney involvement. Because many renal and urological conditions are asymptomatic in their early stages, routine urine testing can flag problems long before you develop pain, visible blood in the urine or changes in kidney function on blood tests.

Proteinuria detection: albumin-to-creatinine ratio (ACR) testing

The presence of excess protein in the urine, known as proteinuria, is a key marker of kidney damage, particularly within the glomeruli—the microscopic filters that clean your blood. In routine practice, laboratories often measure the albumin-to-creatinine ratio (ACR) on a spot urine sample to standardise for urine concentration. Elevated ACR values, even in the “microalbuminuria” range that is invisible on dipstick testing, signal early glomerular injury and strongly predict future cardiovascular and renal events, especially in people with diabetes or hypertension.

Detecting proteinuria as part of a health check has two major advantages. First, it prompts a search for the underlying cause, which may include poorly controlled blood pressure, diabetes, certain medications (such as NSAIDs), or primary kidney diseases. Second, it allows timely intervention with measures known to slow renal decline, such as tighter blood pressure control—often with ACE inhibitors or ARBs—improved glycaemic management, smoking cessation and weight reduction. Think of ACR testing as an early warning alarm for your kidneys: the sooner it sounds, the more time you have to prevent permanent damage.

In many guidelines, annual ACR testing is recommended for people with diabetes and established hypertension, but incorporating it into broader health assessments can identify at-risk individuals earlier. If your routine check reveals raised ACR, your clinician will usually arrange repeat testing to confirm persistence, review your medications and discuss lifestyle steps to protect your kidney function.

Microscopic haematuria investigation and glomerular disease indicators

Microscopic haematuria—the presence of red blood cells in the urine that are not visible to the naked eye—is another important finding on urinalysis. While a single positive result can occasionally be due to contamination (for example, from menstruation) or recent strenuous exercise, persistent haematuria requires further evaluation. Depending on your age, risk factors and associated symptoms, this may involve repeat urine microscopy, imaging of the urinary tract (such as ultrasound or CT urogram) and, in some cases, cystoscopy to inspect the bladder directly.

The potential causes of microscopic haematuria range from relatively benign (such as mild infection or kidney stones) to more serious conditions, including glomerulonephritis and urological malignancies. When haematuria occurs alongside proteinuria, raised blood pressure and reduced kidney function, clinicians are particularly alert to intrinsic glomerular disease, which may require nephrology referral and, occasionally, kidney biopsy. In this way, a simple urine test performed during a routine health check can be the first clue to immune-mediated kidney disorders that would otherwise go unnoticed until advanced.

For you as a patient, the key message is not to ignore microscopic haematuria simply because you feel well. Health checks are designed to pick up such silent abnormalities precisely so they can be investigated before symptoms arise. Early clarification of the cause allows appropriate treatment and monitoring, reducing the risk of long-term renal damage or delayed cancer diagnosis.

Urinary tract infection screening: leucocytes and nitrite presence

Urinalysis also screens for markers of urinary tract infection (UTI), primarily leucocyte esterase (indicating white blood cells) and nitrites (produced when certain bacteria metabolise nitrates in the urine). In symptomatic individuals—those with dysuria, frequency, urgency or suprapubic discomfort—these findings help support a UTI diagnosis and guide antibiotic treatment. However, during a routine health check, they may be discovered in someone who feels entirely well, raising the question: does asymptomatic bacteriuria require treatment?

In most healthy adults, the answer is no; unnecessary antibiotic use can contribute to resistance and side effects without clear benefit. Exceptions include pregnant women and individuals undergoing urological procedures, where treating bacteriuria reduces complication rates. Nevertheless, recurrent or persistent positive results, particularly when accompanied by microscopic haematuria or proteinuria, may prompt further investigation for structural abnormalities, incomplete bladder emptying or kidney stones.

From a preventative health perspective, discussing hydration habits, toileting patterns and genital hygiene as part of your assessment can reduce future UTI risk. For those with recurrent infections, especially post-menopausal women, your clinician might explore strategies such as topical oestrogen, behavioural measures or prophylactic antibiotics in selected cases. Thus, even a “simple” dipstick test becomes a gateway to broader conversations about urinary health and infection prevention.

Body mass index (BMI) and anthropometric measurements for metabolic health

Anthropometric measurements—most commonly body mass index (BMI), waist circumference and, in some assessments, body fat percentage—offer a practical estimate of your body composition and associated metabolic risk. BMI, calculated as weight in kilograms divided by height in metres squared, classifies individuals as underweight, normal weight, overweight or obese according to established cut-offs. However, BMI alone does not distinguish between muscle and fat or capture fat distribution, which is why many clinicians place equal, if not greater, emphasis on waist circumference and waist-to-hip ratio.

Excess adiposity, particularly visceral fat around the abdominal organs, is strongly linked to insulin resistance, type 2 diabetes, dyslipidaemia, non-alcoholic fatty liver disease and cardiovascular disease. A raised waist circumference—typically above 94 cm in men and 80 cm in women of European descent, with lower thresholds for some ethnic groups—signals an increased risk even when BMI falls within the “normal” range. During a routine health check, combining BMI with waist and sometimes body fat percentage provides a more nuanced picture of your metabolic health than any single measurement alone.

What can you do with this information? Firstly, tracking these metrics over time helps you see whether your current lifestyle is moving you towards or away from a healthier body composition, much like watching your bank balance to understand financial trends. Secondly, modest, sustained reductions in weight and waist circumference—often as little as 5–10% of initial body weight—have been shown to produce significant improvements in blood pressure, lipid profiles and glycaemic control. Your clinician can help you set realistic goals, signpost you to local weight management or exercise programmes, and, where appropriate, discuss pharmacological or surgical options for obesity management.

In addition, some health checks incorporate more advanced body composition analysis using bioelectrical impedance or DEXA scanning, which can estimate visceral fat, lean muscle mass and bone density. These data are particularly helpful for tailoring exercise prescriptions—for example, emphasising resistance training to preserve muscle in midlife and beyond—and for monitoring the impact of interventions over time. Ultimately, anthropometric measurements are not about chasing a “perfect” number, but about understanding how your current body composition influences your long-term health and what practical steps you can take to improve it.

Immunisation status and preventative health screening protocols

Routine health checks provide an ideal opportunity to review your immunisation status and ensure you are protected against vaccine-preventable diseases. Many adults assume that vaccinations are only relevant in childhood, yet immunity can wane over time, and additional vaccines become important as you age or develop specific health conditions. During your assessment, clinicians will typically confirm whether you are up to date with tetanus, diphtheria and polio boosters, have received appropriate measles, mumps and rubella (MMR) doses, and, where indicated, have been offered hepatitis B vaccination—particularly if you work in healthcare or have other risk factors.

For older adults and those with chronic conditions, seasonal influenza vaccination, pneumococcal vaccines and, in the UK, the shingles vaccine from age 70 (with evolving eligibility criteria) are key components of preventative care. Recent years have also highlighted the importance of COVID-19 vaccination and boosters for high-risk groups. By systematically checking your vaccine history during a health assessment, clinicians can close any gaps and reduce your risk of serious infections that are more likely to cause complications in later life.

Beyond immunisations, routine health checks align you with evidence-based preventative screening protocols based on age, sex and risk profile. This might include NHS Health Checks for cardiovascular risk from age 40–74, abdominal aortic aneurysm screening for men around age 65, and targeted assessments for conditions such as osteoporosis or chronic lung disease where indicated. Rather than leaving you to navigate a complex screening landscape alone, a well-structured health check acts like a roadmap, clarifying which tests you are due for now, which will be relevant in the future, and how often they should be repeated.

Engaging with these preventative measures can feel like an administrative task, but their impact on population health is substantial. For example, widespread flu vaccination reduces hospital admissions each winter, and cervical and bowel cancer screening programmes have demonstrably lowered mortality from these diseases. By viewing immunisations and screening as integral parts of your routine health maintenance—on par with servicing your car or updating your home insurance—you are far more likely to stay ahead of preventable illness.

Age-specific cancer screening: mammography, cervical cytology and bowel scope programmes

Cancer screening programmes are designed to detect disease at an early, more treatable stage—or, in some cases, to identify precancerous changes before cancer develops at all. As part of a comprehensive health check, your clinician will usually review your eligibility for national screening initiatives and discuss any additional, personalised tests that may be appropriate based on your family history or risk factors. Understanding how and why these programmes operate helps you make informed decisions about participation.

Mammography, the use of low-dose X-rays to image breast tissue, is offered routinely to women within specific age brackets—currently from around 50 to 70 years in the UK, with some areas including women from 47 to 73 as part of an extended trial. The aim is to detect breast cancers before they become palpable or symptomatic, when they are typically smaller and less likely to have spread. While most screening mammograms are normal, a small proportion of women are recalled for further tests, and an even smaller number are diagnosed with cancer. Your routine health assessment is an opportunity to clarify when you are next due a mammogram, weigh the benefits and limitations of screening, and, if you are at higher familial risk, consider more intensive surveillance strategies.

Cervical cytology, commonly known as the smear test, is another cornerstone of cancer prevention, targeting abnormalities in the cervix that may progress to cancer if left untreated. In the modern era, primary high-risk human papillomavirus (HPV) testing is often combined with cytology to refine risk stratification. Women and people with a cervix are usually invited for screening every three years from age 25 to 49 and every five years from 50 to 64, with adjustments for previous abnormal results. Despite some discomfort and embarrassment, attending regular cervical screening has been shown to halve the risk of developing cervical cancer. During a health check, clinicians can address any concerns you may have about the procedure, help you interpret past results and ensure you are on the correct recall schedule.

For bowel cancer, several complementary screening approaches exist. In the UK, most adults are invited to complete a faecal immunochemical test (FIT) at home every two years from their 50s or 60s, depending on local roll-out, while some may also be offered a one-off flexible sigmoidoscopy (“bowel scope”) around age 55. The FIT kit looks for hidden blood in the stool, which can indicate polyps or early cancers, often long before symptoms such as visible bleeding or change in bowel habit appear. A positive result does not necessarily mean you have cancer, but it does prompt further evaluation with colonoscopy. Your routine health assessment is a good time to discuss any barriers you may have to completing bowel screening—such as confusion about the kit or fear of colonoscopy—and to explore alternatives if you are at particularly high risk, for example due to strong family history or inflammatory bowel disease.

Other age- or risk-specific cancer checks may also be considered within the context of a comprehensive health check. These include prostate-specific antigen (PSA) testing for prostate cancer in men over 50, skin examinations for melanoma in individuals with many moles or high UV exposure, and lung cancer screening with low-dose CT in heavy smokers, where available. Each of these has its own balance of benefits and potential harms, such as overdiagnosis or false positives, so shared decision-making is essential. Ultimately, age-specific cancer screening is not about generating anxiety, but about using well-researched tools to shift diagnosis to earlier, more treatable stages—giving you the best possible chance of successful outcomes if cancer does arise.